Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.12 -0.08 (-0.61%)
At close: Oct 22, 2026 · 4:00 PM EDT

Eloxx Pharmaceuticals (ELOX) Non Operating Interest Expenses (2017 - 2018)

Updated

Eloxx Pharmaceuticals' Non Operating Interest Expenses came in at $43,000 for Q1 2018, down 6.5% from $46,000 a year earlier.

Analysis

Eloxx Pharmaceuticals (ELOX) Non Operating Interest Expenses (2017 - 2018) Analysis & Trends

Over the trailing twelve months to Mar 31, 2018, Eloxx Pharmaceuticals reported Non Operating Interest Expenses of $89,000, up 93.5% year-over-year.

  • Going back by year, Non Operating Interest Expenses was $7,000 in FY2016 (-94.3%) and $122,000 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Eloxx Pharmaceuticals 89.89 Mn 16.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 43,000.00
Mar 31, 2017 46,000.00
API Access

Eloxx Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ELOX&period=max&api_key=YOUR_API_KEY